Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.

MLA

Chihana, Rachel, et al. “Factors Associated with Reactogenicity to an Investigational HIV Vaccine Regimen in HIV Vaccine Trials Network 702.” Vaccine, vol. 42, no. 20, Aug. 2024, p. 125991. EBSCOhost, https://doi.org/10.1016/j.vaccine.2024.05.039.

APA

Chihana, R., Jin Kee, J., Moodie, Z., Huang, Y., Janes, H., Dadabhai, S., Roxby, A. C., Allen, M., Kassim, S., Naicker, V., Innes, C., Naicker, N., Dubula, T., Grunenberg, N., Malahleha, M., Kublin, J. G., Bekker, L.-G., Gray, G., Kumwenda, J., & Laher, F. (2024). Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine, 42(20), 125991. https://doi.org/10.1016/j.vaccine.2024.05.039

Chicago

Chihana, Rachel, Jia Jin Kee, Zoe Moodie, Yunda Huang, Holly Janes, Sufia Dadabhai, Alison C Roxby, et al. 2024. “Factors Associated with Reactogenicity to an Investigational HIV Vaccine Regimen in HIV Vaccine Trials Network 702.” Vaccine 42 (20): 125991. doi:10.1016/j.vaccine.2024.05.039.